Japan vs Mongolia: Number of isolates tested for ceftriaxone
Japan
134
in 2020
Mongolia
129
in 2018
Japan rank
22nd
Mongolia rank
24th
Number of isolates tested for ceftriaxone over time
- Japan
- Mongolia
How they compare
Japan currently reports 134 against 129 in Mongolia, a difference of 5.
The two have swapped places 3 times across 6 shared years of data; in 2009 it was Mongolia ahead.
Japan ranks 22nd and Mongolia ranks 24th of 52 countries.
Across the 2 decades both report, Japan averaged higher in 1 and Mongolia in 1.
Head to head by decade
| Decade | Japan | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 403 | 690 | 287 | Mongolia |
| 2010s | 452.4 | 210.2 | 242.2 | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Japan or Mongolia?
- Japan, at 134 against 129 in Mongolia as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Japan and Mongolia?
- 5, with Japan ahead.
- How many years of comparable data are there for Japan and Mongolia?
- 6 years are reported by both, from 2009 to 2018.
- How do Japan and Mongolia rank globally for number of isolates tested for ceftriaxone?
- Japan ranks 22nd and Mongolia ranks 24th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.